Human Disease | Mouse Models | ||||
---|---|---|---|---|---|
|
IDs
|
View 1 model | |||
IDs
|
View 2 models | ||||
|
IDs
|
||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
|||||
IDs
|
early conceptus |
embryo ectoderm |
embryo endoderm |
embryo mesoderm |
embryo mesenchyme |
extraembryonic component |
alimentary system |
auditory system |
branchial arches |
cardiovascular system |
connective tissue |
endocrine system |
exocrine system |
hemolymphoid system |
integumental system |
limbs |
liver and biliary system |
musculoskeletal system |
nervous system |
olfactory system |
reproductive system |
respiratory system |
urinary system |
visual system |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transcription Start Site | Location | Distance from Gene 5'-end |
Tssr14965 | Chr1:170804136-170804177 (-) | -41 bp |
Tssr14964 | Chr1:170803681-170803689 (-) | 431 bp |
Tssr14963 | Chr1:170803613-170803675 (-) | 472 bp |
Tssr14962 | Chr1:170803592-170803607 (-) | 516 bp |
Tssr14961 | Chr1:170803573-170803584 (-) | 537 bp |
Tssr14960 | Chr1:170800428-170800436 (-) | 3,684 bp |
Tssr14959 | Chr1:170799528-170799530 (-) | 4,587 bp |
Tssr14958 | Chr1:170795773-170795794 (-) | 8,332 bp |
Tssr14957 | Chr1:170794054-170794092 (-) | 10,043 bp |
Tssr14956 | Chr1:170793364-170793380 (-) | 10,744 bp |
Tssr14955 | Chr1:170788654-170788674 (-) | 15,452 bp |
Tssr14954 | Chr1:170788425-170788436 (-) | 15,685 bp |
Tssr14953 | Chr1:170787658-170787669 (-) | 16,452 bp |
Tssr14952 | Chr1:170787643-170787654 (-) | 16,467 bp |
Tssr284 | Chr1:170787463-170787468 (-) | 16,650 bp |
Tssr14951 | Chr1:170787386-170787409 (-) | 16,718 bp |
Tssr14950 | Chr1:170787308-170787340 (-) | 16,792 bp |
Tssr14949 | Chr1:170786464-170786486 (-) | 17,641 bp |
QTL | Genetic Location* | Genome Location (GRCm39) | Reference | QTL Note |
Lmr20 | Chr1, syntenic | Chr1:175468817-175468938 | J:152405 | Potential candidated genes mapping near Lmr20, Lmr20a, Lmr20b and Lmr20c which mapped to D1Mit403 at 100.0 cM of CcS11/Dem in this study are: Fcer1a, Fc receptor, IgE, high affinity I, alpha polypeptide at 94.2 cM; Fcer1g, Fc receptor, IgE, high affinity I, gamma polypeptide at 93.3 cM; Fcgr2b, Fc receptor, IgG, low affinity IIb at 92.3 cM; Cluster of IFN activated genes: Ifi201,Ifi202a; Ifi203, and Ifi204 between 95.2-95.3 cM; and Tgfb2, transforming growth factor, beta 2 at 101.5 cM. [Table 9.] Possibly related QTL controlling other infections and co-localizing with the Lmr20 QTL are: Tir3c, trypanosome infection response 3c at 93.0 cM; Ssta2, susceptibility to Salmonella typhimurium antigens 2 at 95.8 cM; Bbaa12, B.burgdorferi-associated arthritis 12 at 96.0 cM; and, Berr1, berghei resistance locus 1 at 102.0 cM; [Table 10]. |
Lmr20a | Chr1, syntenic | Chr1:175468817-175468938 | J:152405 | Potential candidated genes mapping near Lmr20, Lmr20a, Lmr20b and Lmr20c which mapped to D1Mit403 at 100.0 cM of CcS11/Dem in this study are: Fcer1a, Fc receptor, IgE, high affinity I, alpha polypeptide at 94.2 cM; Fcer1g, Fc receptor, IgE, high affinity I, gamma polypeptide at 93.3 cM; Fcgr2b, Fc receptor, IgG, low affinity IIb at 92.3 cM; Cluster of IFN activated genes: Ifi201,Ifi202a; Ifi203, and Ifi204 between 95.2-95.3 cM; and Tgfb2, transforming growth factor, beta 2 at 101.5 cM. [Table 9.] Possibly related QTL controlling other infections and co-localizing with the Lmr20 QTL are: Tir3c, trypanosome infection response 3c at 93.0 cM; Ssta2, susceptibility to Salmonella typhimurium antigens 2 at 95.8 cM; Bbaa12, B.burgdorferi-associated arthritis 12 at 96.0 cM; and, Berr1, berghei resistance locus 1 at 102.0 cM; [Table 10]. |
Lmr20b | Chr1, syntenic | Chr1:175468817-175468938 | J:152405 | Potential candidated genes mapping near Lmr20, Lmr20a, Lmr20b and Lmr20c which mapped to D1Mit403 at 100.0 cM of CcS11/Dem in this study are: Fcer1a, Fc receptor, IgE, high affinity I, alpha polypeptide at 94.2 cM; Fcer1g, Fc receptor, IgE, high affinity I, gamma polypeptide at 93.3 cM; Fcgr2b, Fc receptor, IgG, low affinity IIb at 92.3 cM; Cluster of IFN activated genes: Ifi201,Ifi202a; Ifi203, and Ifi204 between 95.2-95.3 cM; and Tgfb2, transforming growth factor, beta 2 at 101.5 cM. [Table 9.] Possibly related QTL controlling other infections and co-localizing with the Lmr20 QTL are: Tir3c, trypanosome infection response 3c at 93.0 cM; Ssta2, susceptibility to Salmonella typhimurium antigens 2 at 95.8 cM; Bbaa12, B.burgdorferi-associated arthritis 12 at 96.0 cM; and, Berr1, berghei resistance locus 1 at 102.0 cM; [Table 10]. |
Lmr20c | Chr1, syntenic | Chr1:175468817-175468938 | J:152405 | Potential candidated genes mapping near Lmr20, Lmr20a, Lmr20b and Lmr20c which mapped to D1Mit403 at 100.0 cM of CcS11/Dem in this study are: Fcer1a, Fc receptor, IgE, high affinity I, alpha polypeptide at 94.2 cM; Fcer1g, Fc receptor, IgE, high affinity I, gamma polypeptide at 93.3 cM; Fcgr2b, Fc receptor, IgG, low affinity IIb at 92.3 cM; Cluster of IFN activated genes: Ifi201,Ifi202a; Ifi203, and Ifi204 between 95.2-95.3 cM; and Tgfb2, transforming growth factor, beta 2 at 101.5 cM. [Table 9.] Possibly related QTL controlling other infections and co-localizing with the Lmr20 QTL are: Tir3c, trypanosome infection response 3c at 93.0 cM; Ssta2, susceptibility to Salmonella typhimurium antigens 2 at 95.8 cM; Bbaa12, B.burgdorferi-associated arthritis 12 at 96.0 cM; and, Berr1, berghei resistance locus 1 at 102.0 cM; [Table 10]. |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|